Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06592157

Factors Influencing Wound Healing After Anal Fistula Surgery

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
600 (estimated)
Sponsor
Taichung Veterans General Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of this observational study is to analyze the factors influencing wound healing after anal fistula surgery and to assess the effectiveness of interventions in improving overall patient outcomes post-surgery. The primary questions this study aims to answer are: 1. Does the use of the growth factor (New Epi) contribute to accelerating wound healing, reducing the risk of infection, and enhancing patient recovery speed after surgery? 2. Do other factors, such as infection, nutritional status, diabetes, surgical methods, patient age and overall health, immune status, and lifestyle habits, affect the healing of surgical wounds?

Conditions

Interventions

TypeNameDescription
OTHERNewEpi Plus Liquid Wound Dressing1. Hold the spray nozzle 7-10 cm away from the wound. Apply the product evenly over the wound, with a dosage of one spray (0.1 ml) per 10x10 cm² of wound area. 2. Wait for 2 minutes. It is not necessary to wait until the solution is completely dry; you can proceed with applying ointments and various types of dressings as directed by the physician. 3. Use once a day for 21 days. The frequency of use can be adjusted according to the physician\'s instructions.
OTHERstandard wound careThe standard wound care protocol aims to provide comprehensive and systematic care for patients to ensure smooth healing of surgical wounds. These care measures include regular cleaning, disinfection, dressing changes, and continuous observation and assessment of the wound condition. Through strict aseptic techniques and scientific care procedures, standard wound care effectively reduces the risk of infection and promotes wound healing.

Timeline

Start date
2024-09-10
Primary completion
2026-06-30
Completion
2026-06-30
First posted
2024-09-19
Last updated
2024-09-19

Source: ClinicalTrials.gov record NCT06592157. Inclusion in this directory is not an endorsement.